Enzymatica AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2021. For the fourth quarter, the company reported sales was SEK 18.74 million compared to SEK 42.26 million a year ago. Net loss was SEK 10.76 million compared to SEK 0.321 million a year ago. Basic loss per share from continuing operations was SEK 0.07.
For the full year, sales was SEK 57.24 million compared to SEK 111.25 million a year ago. Net loss was SEK 45.39 million compared to SEK 13.22 million a year ago. Basic loss per share from continuing operations was SEK 0.31 compared to SEK 0.09 a year ago.